Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Margin: 2017-2020

Historic Operating Margin for Cogent Biosciences (COGT) over the last 4 years, with Sep 2020 value amounting to -18,333.01%.

  • Cogent Biosciences' Operating Margin fell 1715301.00% to -18,333.01% in Q3 2020 from the same period last year, while for Sep 2020 it was -295.79%, marking a year-over-year increase of 9838.00%. This contributed to the annual value of -1,044.33% for FY2020, which is 90131.00% down from last year.
  • As of Q3 2020, Cogent Biosciences' Operating Margin stood at -18,333.01%, which was down 1,207.56% from -1,402.08% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' Operating Margin ranged from a high of 14.65% in Q4 2019 and a low of -18,333.01% during Q3 2020.
  • Over the past 3 years, Cogent Biosciences' median Operating Margin value was -387.85% (recorded in 2019), while the average stood at -2,122.46%.
  • Data for Cogent Biosciences' Operating Margin shows a peak YoY increase of 30,051bps (in 2020) and a maximum YoY decrease of 1,715,301bps (in 2020) over the last 5 years.
  • Over the past 4 years, Cogent Biosciences' Operating Margin (Quarterly) stood at -324.07% in 2017, then skyrocketed by 8,743bps to -236.64% in 2018, then surged by 25,129bps to 14.65% in 2019, then slumped by 1,715,301bps to -18,333.01% in 2020.
  • Its Operating Margin was -18,333.01% in Q3 2020, compared to -1,402.08% in Q2 2020 and -87.34% in Q1 2020.